Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2011284.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synairgen Research Ltd
Original Assignee
Synairgen Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synairgen Research LtdfiledCriticalSynairgen Research Ltd
Priority to GBGB2011284.3ApriorityCriticalpatent/GB202011284D0/en
Publication of GB202011284D0publicationCriticalpatent/GB202011284D0/en
Priority to EP21749262.8Aprioritypatent/EP4181944A1/en
Priority to PCT/GB2021/051853prioritypatent/WO2022018422A1/en
Priority to JP2023504184Aprioritypatent/JP2023535710A/en
Priority to KR1020237005777Aprioritypatent/KR20230041097A/en
Priority to US18/016,964prioritypatent/US20230338475A1/en
Treatment of hepatitis c virus infections with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interfer0n-alpha-2a/2b and ribavirin